The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 28, 2025

Filed:

Feb. 28, 2023
Applicants:

Massachusetts Institute of Technology, Cambridge, MA (US);

Children's Medical Center Corporation, Boston, MA (US);

Whitehead Institute for Biomedical Research, Cambridge, MA (US);

Inventors:

Richard O. Hynes, Winchester, MA (US);

Noor Jailkhani, Cambridge, MA (US);

Hidde L. Ploegh, Boston, MA (US);

Yushu J. Xie, Brookline, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/42 (2025.01); A61K 47/68 (2017.01); A61K 49/00 (2006.01); A61K 49/08 (2006.01); A61K 51/10 (2006.01); A61P 35/04 (2006.01); B82Y 5/00 (2011.01); C07K 14/78 (2006.01); C07K 16/18 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
C07K 16/2842 (2013.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/42 (2025.01); A61K 47/6809 (2017.08); A61K 47/6813 (2017.08); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); A61K 49/0058 (2013.01); A61K 49/085 (2013.01); A61K 51/1027 (2013.01); A61K 51/1045 (2013.01); A61K 51/1051 (2013.01); A61K 51/1057 (2013.01); A61K 51/1093 (2013.01); A61P 35/04 (2018.01); C07K 14/78 (2013.01); C07K 16/18 (2013.01); C12N 5/0636 (2013.01); A61K 2039/505 (2013.01); A61K 2239/13 (2023.05); A61K 2239/31 (2023.05); A61K 2239/38 (2023.05); A61K 2239/57 (2023.05); B82Y 5/00 (2013.01); C07K 2317/22 (2013.01); C07K 2317/569 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01);
Abstract

Methods for developing disease-related nanobodies and related products and kits are provided. The disease-specific proteins are extracellular matrix (ECM) proteins, domains or epitopes that are associated with various aspects of disease and are not present, or are present in very low quantities, in non-diseased individuals. Highly effective nanobodies capable of specifically binding to these ECM protein epitopes useful in in vivo imaging assays, the detection, diagnosis and treatment of diseases as well as monitoring therapeutic progress in a patient with a disease are provided herein.


Find Patent Forward Citations

Loading…